Plozalizumab Biosimilar – Anti-CCR2, CD192 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product namePlozalizumab Biosimilar - Anti-CCR2, CD192 mAb - Research Grade
SourceCAS 1610761-46-0
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsPlozalizumab,MLN-1202,anti-CCR2,hu1D9,CCR2, CD192,anti-CCR2, CD192
ReferencePX-TA1395
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Plozalizumab Biosimilar - Anti-CCR2, CD192 mAb - Research Grade

General information on Anti-CCR2/CD192[Homo sapiens] (Plozalizumab) Monoclonal Antibody

Plozalizumab is a humanized monoclonal antibody that targets CCR2 chemokine receptors found on the surface of white blood cells such as macrophages and monocytes. Plozalizumab has been investigated to treat Atherosclerosis. CCR2 is supposed to play an important role in the trafficking of monocytes and macrophages to sites of inflammation.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Plozalizumab Biosimilar – Anti-CCR2, CD192 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products